Search Within
Document Type
83-67-0
Applied Filters:
Keyword:'83-67-0'
Showing 1-30 of 188 results for "83-67-0" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
90 101 82 61
48 75 38 99 86 8 6 54 66 10 83 105 106 103
99 98 103 104 101 67 95 77 101 95 82 99 67 96 90 76 93 63 98 105
The Effective Use of Protein Kinase Inhibitors
90 101 82 61
48 75 38 99 86 8 6 54 66 10 83 105 106 103
99 98 103 104 101 67 95 77 101 95 82 99 67 96 90 76 93 63 98 105
LABORATORY NOTEBOOK ISSUANCE PAGE
22
22
.9
90
24
.3
05
39
.0
98
40
.0
78
85
.4
68
87
.6
2
13
2.
91
13
7.
33
(2
23
)
(2
26
)
44
.9
56
47
.8
67
50
.9
LABORATORY NOTEBOOK ISSUANCE PAGE
22
22
.9
90
24
.3
05
39
.0
98
40
.0
78
85
.4
68
87
.6
2
13
2.
91
13
7.
33
(2
23
)
(2
26
)
44
.9
56
47
.8
67
50
.9
LABORATORY NOTEBOOK ISSUANCE PAGE
22
22
.9
90
24
.3
05
39
.0
98
40
.0
78
85
.4
68
87
.6
2
13
2.
91
13
7.
33
(2
23
)
(2
26
)
44
.9
56
47
.8
67
50
.9
Product Information Sheet - T4680
myocyte
hypertrophy is associated with c-myc
protooncogene expression. Proc. Natl. Acad. Sci.
USA, 83(21), 8348-8350 (1986).
5. Kyprianou, N., and Benning, C. M., Suppression of
human prostate cancer
Product Information Dulbecco’s Modified Eagle’s Medium (DMEM)
Choline chloride 67-48-1 0.0040
17 Folic acid 59-30-3 0.0040
18 Myo-Inositol 87-89-8 0.0072
19 Nicotinamide 98-92-0 0.0040
20 Pyridoxine hydrochloride 58-56-0 0.0040
21 Riboflavin 83-88-5 0.0004
22 Thiamine
Anti-NeuN, clone A60 - Data Sheet
:441-445.
81) Ma, D.L., et al., J Neuroscience Research (2006) 83:318-331.
82) Sakaguchi, M, et al., PNAS (2006) 103:7112-7117.
83) Koizumi, H., et al., Nature Neuroscience (2006) 9:779-786.
84)
Glasgow's Minimum Essential Medium (GMEM) Product Information EMD
chloride 67-48-1 0.00200
16 Pyridoxal hydrochloride 65-22-5 0.00200
17 Folic acid 59-30-3 0.00200
18 Myo-Inositol 87-89-8 0.00360
19 Nicotinamide 98-92-0 0.00200
20 Riboflavin 83-88-5 0.00020
User Guide-RAB0178
70-87
Plasma 73 67-86
Cell Culture Supernatants 77 70-90
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 92 101 102
Range (%) 83-104 89-110 92-109
User Guide-RAB0403
Plasma 109 92-129
Cell Culture Supernatants 74 67-83
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 79 83 76
Range (%) 70-89 74-91 69-87
1:4
Average
User Guide-RAB1049
Plasma 82 67-93
Cell Culture Supernatants 72 68-82
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 89 75 81
Range (%) 83-94 68-83 76-86
1:4
Average
User Guide-RAB0321
are as follows:
Sample Type Average % Recovery Range (%)
Serum 75 67-82
Plasma 74 67-81
Cell Culture Supernatants 76 68-83
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
Product Information Sheet - RAB0248
Expected 75.67 74.76 76.49
Range
Periodic table Poster
3d24s2
23 50.942 1910
3407
1.45V
0, 2, 3, 4, 5
[Ar] 3d34s2
24 51.996 1907
2671
1.56Cr
0, 2, 3, 6
[Ar] 3d54s1
25 54.938 1246
2061
1.60Mn
-1, 0, 2, 3, 4
Periodic Table of the Elements - Certipur ICP multi-element standards according to USP <232> - EMD
3d24s2
23 50.942 1910
3407
1.45V
0, 2, 3, 4, 5
[Ar] 3d34s2
24 51.996 1907
2671
1.56Cr
0, 2, 3, 6
[Ar] 3d54s1
25 54.938 1246
2061
1.60Mn
-1, 0, 2, 3, 4
Protocol- PRCYTA-40K|PRCYTA-40K-PX38|PRCYTA-40K-BK38|PRCYTA-40K-PX48|PRCYTA-40K-BK48
1α 86 89
Granzyme A 85 85
IFNα2 84 83
IL-10 91 94
IL-2 83 86
IL-15 84 84
IL-17A 85 86
IL-6 83 86
Relationship of MC-Media Pad E. coli & Coliform Plate Results with the Most Probable Number Method
79 1.898 1.807 64.160
80 1.903 1.812 64.933
81 1.908 1.818 65.706
82 1.914 1.823 66.478
83 1.919 1.828 67.250
84 1.924 1.833 68.022
85 1.929 1.838 68.793
86 1.934 1.842 69.563
Specification Sheet: NovAseptic® Mixer Drive Unit, GMP ATEX
D
-E2-###
NovAseptic® ATEX
Mixer assembly type
AX05/41 281 (11.06) 145 (5.71) 123 (4.84) 83 (3.27) –055 125 (4.92) –056 — — GMP50 ATEX
AX1/41 281 (11.06) 145 (5.71) 123 (4.84) 71 (2.80) –057
User Guide-RAB1396
Mean recoveries are as follows:
Sample Type Average % Recovery Range (%)
Serum 73 67-83
Plasma 72 68-83
Cell Culture Supernatants 82 76-93
Linearity
Sample Type Serum Plasma Cell Culture
MMP-9 Immunoassay Kit, proform only - Data Sheet
recognizes free pro-MMP-9, intermediate 83 kDa MMP-9, and
MMP-9 in complex with TIMP-1 with the same efficiency. The assay does not
recognize active MMP-9 (67 kDa). Contents of this kit are sufficient
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
00
0
7,
00
0
8,
00
0
9,
00
0
0
50
,0
00
10
0,
00
0
15
0,
00
0
20
0,
00
0
25
0,
00
0
30
0,
00
010 10
0
1,
00
0
10
,0
00
10
0,
00
0
10 10
0
1,
00
0
10
,0
00
User Guide-RAB1295
Supernatants
1:2
Average % of Expected 71 77 79
Range (%) 68-74 67-87 73-84
1:4
Average % of Expected Range 71 82 83
Range (%) 67-74 89-112 79-88
4
RAB1295pis Rev 08/24
User Guide-RAB0047
Supernatants
1:2
Average % of Expected 92 101 102
Range (%) 83-104 89-110 92-109
1:4
Average % of Expected Range 71 76 83
Range (%) 67-81 69-86 73-94
4
RAB0047pis Rev 08/24
User Guide-RAB0097
Expected 82 102 101
Range (%) 70-94 92-120 93-109
1:4
Average % of Expected Range 87 75 83
Range (%) 80-92 67-83 68-90
4
RAB0097pis Rev 08/24
Reproducibility
Fast GC-A Practical Guide for Increasing Sample Throughput without Sacrificing Quality
53
54
55
56
5758
59
60
61
62
63
64
65
66 67
68
69
70
71
74
75 78
79
80
81
82
83
Periodic table A4
Unknown title
S
ta
n
d
:
0
1
/2
0
1
7
W
.2
8
0
7
1
8
The life science business of Merck
Brochure
75% 73%
Sample dilution IFNg IL-1 TNFa VEGF-A
Standards diluted
in serum matrix Neat 83% 117% 77% 67%
Figure 2. Standard curves of 39 analytes in the
Human Cytokine/Chemokine Panel (HCYTOMAG
Non-Human Primate Cytokine/Chemokine/Growth Factor Panel A Magnetic Bead Panel
85
IFNα2 84 83
IL-10 91 94
IL-2 83 86
IL-15 84 84
IL-17A 85 86
IL-6 83 86
Granzyme B 88 85
IL-8 85 83
IL-1Ra 86 90
IL-1β 80 87
IL-23 93
Protocol- EQCYTMAG-93K
IL-1α 89 83
GM-CSF 92 87
Fractalkine 91 85
IL-13 85 79
IL-5 92 85
IL-18 94 89
IL-1β 92 88
IL-6 83 76
Page 1 of 7